P27 was identified as a tumor suppressor nearly two decades, being implicated in cell-cycle control, differentiation, senescence, apoptosis and motility. Our present study, for the first time to the best of our knowledge, revealed a potential role of p27 in inhibiting S6-mediated hypoxia-inducible factor-1α (HIF-1α) protein translation, which contributed to the protection from environmental carcinogen (sodium arsenite)-induced cell transformation. Our findings showed that depletion of p27 expression by knockout and knockdown approaches efficiently enhanced S6 phosphorylation in arsenite response via overactivating Ras/Raf/ MEK/ERK pathway, which consequently resulted in the stimulation of p90RSK (90 kDa ribosomal S6 kinase), a direct kinase for S6 phosphorylation. Although PI3K/AKT pathway was also involved in S6 activation, blocking AKT and p70S6K activation did not attenuate arsenite-induced S6 activation in p27 − / − cells, suggesting p27 specifically targeted Ras/ERK pathway rather than PI3K/AKT pathway for inhibition of S6 activation in response to arsenite exposure. Further functional studies found that p27 had a negative role in cell transformation induced by chronic low-dose arsentie exposure. Mechanistic investigations showed that HIF-1α translation was upregulated in p27-deficient cells in an S6 phosphorylation-dependent manner and functioned as a driving force in arsenite-induced cell transformation. Knockdown of HIF-1α efficiently reversed arsenite-induced cell transformation in p27-depleted cells. Taken together, our findings provided strong evidence showing that by targeting Ras/ERK pathway, p27 provided a negative control over HIF-1α protein synthesis in an S6-dependent manner, and abrogated arsenite-induced cell transformation via downregulation of HIF-1α translation. Numerous physiological, pathological and pharmacological stimuli have been reported to cause S6 phosphorylation, which results in the regulation of global protein synthesis, cell growth, proliferation and glucose homeostasis.
Numerous physiological, pathological and pharmacological stimuli have been reported to cause S6 phosphorylation, which results in the regulation of global protein synthesis, cell growth, proliferation and glucose homeostasis. 1 The phosphorylation sites of mammals S6 have been mapped to the C-terminal region at five clustered serine residues, for example, S235/236/240/244/247, which are evolutionarily conserved in higher eukaryotes. [2] [3] [4] [5] [6] [7] [8] [9] [10] Clinically hyperphosphorylation of S6 is frequently observed in human malignancies, such as breast cancer, 11 sarcoma 12 and acute leukemia. 13 Increased phosphorylation of S6, along with increased phosphorylation of translation initiation factor 4E-binding protein 1, increased expression of eukaryotic elongation factor 2 kinase and decreased expression of programmed cell death protein 4 have been categorized as four major aberrations of the translation process implicated in breast cancer when predicting overall survival or recurrence-free survival of patients. 11, 14, 15 Therefore, targeting S6 phosphorylation and its related signaling pathway is a conventional strategy implicated in therapeutic intervention of human cancers. 16 However, the findings obtained from S6 P − / − knock-in mice, which contained replacement of all five serine residues with alanines, have complicated our understandings about the role of S6 phosphorylation in protein synthesis. 17 Contradictory to the previous observations, defects in S6 phosphorylation even increased global protein synthesis rate. 17 One suggested mechanism is that S6 phosphorylation might specifically regulate each step of protein translation, 18 namely S6 phosphorylation might finely upregulate translation initiation, while downregulate other critical steps of translation, such as elongation and termination. 18 It is also likely that the effect of S6 phosphorylation on protein translation is genespecific, depending on the individual transcript stereoscopic structure or depending on the type of initiation steps, such as cap-or IRES-mediated translation initiation. Further investigations to discriminate these possibilities will help envision the exact function of S6 phosphorylation.
P27 is initially identified as a potent negative cell-cycle regulator that preferentially binds to and inhibits cyclin D-CDK4/6 and cyclin E/A-CDK2 complexes. 19, 20 Later, more in-depth studies indicate that p27 is a multifunctional protein that exerts additional activities on apoptosis, cell adhesion and migration, independent of its cyclin/CDK binding and inhibition properties. 19, [21] [22] [23] [24] [25] Our present study, for the first time to the best of our knowledge, revealed a potential role of p27 in inhibiting hif-1a mRNA translation via regulating Ras/Raf/ MEK/ERK pathway that was responsible for the stimulation of p90RSK (90 kDa ribosomal S6 kinase), the direct kinase for S6 phosphorylation. Further functional studies demonstrated that through inhibiting S6-mediated hypoxia-inducible factor-1α (HIF-1α) translation, p27 contributed to the protection from environmental carcinogen (sodium arsenite)-induced cell transformation. Therefore, from a novel point of view, our findings provide one more piece of strong evidence for the suppressive role of p27 in the process of tumor promotion and progression in arsenic response, which is achieved by inhibition of HIF-1α protein translation.
Results
P27 inhibited arsenite-induced ribosomal protein S6 phosphorylation. Mouse embryonic fibroblast (MEF) is a relatively less differentiated mesodermally derived cell type, so that most genes are actively transcribed and translated in MEF. Therefore, MEF is widely used in the studies of differentiation, transformation, senescence and apoptosis. 26, 27 We used two pairs of p27 − / − MEFs and their littermated p27+/+ MEFs to minimize the off-target effects generated during cell line establishment, one being named as p27 − / − (Δ51) 28 because of the deletion of N-terminal 51 amino acids, and the other named as p27 − / − (FL) because it harbored deletion of the entire coding region 29 ( Figures 1a and b , top panels). Using these cells, we found that arsenite treatment caused a strong induction of phospho-S6 at S235/236 in p27 − / − cells compared with that in p27+/+ cells at all the time points tested (3-12 h), regardless of the knockout methods used (Figures 1a and b , bottom panels), indicating that p27 might abrogate arsenite-induced S6 phosphorylation at S235/236. Elevations of phospho-S6 at S235/236 were also observed in the stable transfectants of shRNA p27 generated from MEFs and their respective wild-type cells were seeded into 6-well plates and cultured overnight in the normal medium containing 10% FBS. Then, the cells were starved for 36 h in the fresh medium with 0.1% FBS. Later, the cells were then exposed to 10 and 20 μM arsenite for the indicated time periods in the fresh medium with 0.1% FBS . Western blotting assay was carried out for the detection of total and phospho-S6. β-Actin was used as a loading control. (c-f) Wild-type MEFs generated from different mouse strain backgrounds and gestational ages as summarized (c) were stably transfected with short hairpin RNA (shRNA) p27. The stable transfectants of shRNA p27 and the nonsense controls were treated with arsenite as indicated. Western blotting assay was carried out to compare S6 phosphorylation (d-f). (g) Mouse epidermal Cl41 cells were stably transfected with shRNA p27 to detect S6 phosphorylation after arsenite treatment of different backgrounds and gestational ages, 28, 30, 31 ( Figures 1c-f ) as well as from mouse epidermal Cl41 cells (Figure 1g ), indicating that the inhibitory effect of p27 on arsenite-induced S6 phosphorylation at S235/236 was prevalent, which was neither cell type-specific nor developmental stage-dependent.
Our findings were further enforced by reconstitution experiment, in which either the full-length human p27 or the N-terminal region (aa 1-51) of p27 that was fused to 3′ GFP-tag was delivered into p27 − / − (Δ51) cells by adenovirus (Figure 2a ) or stable transfection (Figure 2b ). In both cases, an obvious inhibition of arsenite-induced phospho-S6 at S235/236 was observed (Figures 2a and b) . To verify that the remaining C-terminal portion of p27 (aa in p27 − / − (Δ51) cells was not able to fulfill the function of fulllength p27, we stably transfected the full-length GFP-tagged p27 and C terminus (aa 78-198) of p27 into p27 − / − (FL) cells, respectively. As shown in Figure 2c , the expression of full-length p27 was able to completely abrogate induction of phospho-S6 by arsenite, whereas transfection of C terminus of p27 (aa 78-198) did not render the repressive effect, indicating that the N terminus of p27 (aa 1-51) was critical for its inhibitory effect on S6 phosphorylation induced by arsenite.
AKT/p70S6K pathway was not responsible for hyperphosphorylation of S6 caused by p27 depletion. We examined activation of p70S6K using phospho-T421/ S424 as an indicative marker. As shown in Figures 3a and b , the phosphorylations of p70S6K on T421/S424 induced by arsenite were elevated in p27 − / − cells compared with those in p27+/+ cells at all the time points examined in both pairs of knockout cells. The findings were further reproduced in shRNA p27 transfectants of both MEFs and Cl41 cells (Figures 3c and d) , suggesting that arsenite-induced activation of p70S6K was upregulated upon p27 depletion. Next, to determine the involvement of p70S6K in the activation of S6 in p27-depleted cells, we stably transfected two sets of shRNA against p70S6K into p27 − / − (Δ51) cells (Figure 3e , upper panels) and checked S6 phosphorylation induced by arsenite. As shown in Figure 3e (lower panels), in both p70S6K-knockdown transfectants arsenite-induced phosphorylation of p70S6K was apparently reduced but not that of S6, indicating that p70S6K was not the upstream kinase that was responsible for the elevated S6 phosphorylation in p27-depleted cells in response to arsenite.
In our current studies, we found that arsenite-induced phospho-AKT S473 was elevated in p27 − / − cells and shRNA p27 transfectants when compared with that in wild-type and nonsense control cells, respectively (Figures 4a and b) . (Figure 5h ). Therefore, we concluded that ERK/p90RSK pathway participated in S6 phosphorylation induced by arsenite in p27-depleted cells.
P27 inhibited activation of Ras/Raf/MEK pathway. To determine how p27 inhibits ERK activation in arsenite response, the activation of upstream kinases, the Raf/MEK cascade, was compared between p27+/+ and p27 − / − cells. As shown in Figure 6a , phosphorylations of c-Raf at S289-/296/301 and S338, the central points for controlling Raf activation, were found substantially upregulated by arsenite in Figure 3 The inhibitory effect of p27 on S6 phosphorylation is not due to p70S6K. P27 − / − (Δ51) (a) and p27 − / − (FL) cells (b) and their respective wild-type cells were seeded into 6-well plates and cultured overnight in the normal medium containing 10% FBS. Then, the cells were starved for 36 h in the fresh medium with 0.1% FBS. Later, the cells were exposed to 10 and 20 μM arsenite for the indicated time periods (a) or 6 h (b) in the fresh medium with 0.1% FBS. Western blotting assay was carried out for the detection of total and phospho-S6. β-Actin was used as a loading control. (c and d) Short hairpin RNA (shRNA) p27 stable transfectants of wild-type MEFs (c) and Cl41 (d) were treated with 10 and 20 μM arsenite for the indicated time periods. The cells were lysed and subjected to western blotting assay for the detection of total and phospho-p70S6K. (e) Two sets of shRNA against mouse p70S6K were transfected into p27 − / − (Δ51) cells and the stable transfectants were identified using anti-p70S6K antibody. The indicated cells were exposed to arsenite and activation of p70S6K and S6 was assessed by western blotting assay 
To prove this, we transfected GFP-tagged dominant-negative form of Ras, S17N, into p27 − / − (Δ51) cells. Our results showed that overexpression of Ras S17N efficiently blocked activation of Raf/MEK/ERK cascade, further leading to the impairment of p90RKS and S6 phosphorylations (Figure 6d) . Thus, the results demonstrated that by deactivating Ras/Raf/MEK/ERK/p90RSK pathway, p27 inhibited arsenite-induced S6 phosphorylation.
P27 maintained PHLPP expression and promoted its inhibitory activity toward Ras/ERK/p90RSK cascade. As a member of the small GTPase family, Ras oscillates between an inactive GDP-bound state in the cytosol and an active GTP-bound form in the plasma membrane. 32 Recent studies suggest that pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP) has an important role in regulating Ras activation by interacting with guanine nucleotide-free form of Ras, hampering nucleotide binding for Ras activation, thereby negatively modulating downstream ERK pathway activation.
32,33 Therefore, we checked the expression of PHLPP in p27+/+ and p27 − / − (Δ51) cells. As shown in Figure 6e , the basal level of PHLPP was depleted in p27 − / − (Δ51) cells, and arsenite treatment decreased PHLPP1 expression in p27+/+ cells. To verify whether the impaired expression of PHLPP in p27 − / − (Δ51) cells led to increment in Ras/ERK/S6 pathway activation, we stably transfected HA-PHLPP into p27 − / − (Δ51) cells, and the transfectants were identified by overexpression of HA and PHLPP (Figure 6f ). The ectopic expression of HA-PHLPP markedly reduced the activation of Raf/MEK/ERK/p90RSK/S6 cascade (Figure 6g) . Therefore, we concluded that PHLPP expression was maintained by p27 and mediated the deactivation of Ras/ERK/S6 pathway in arsenite response.
P27 inhibited HIF-1α translation because of arsenite exposure. To investigate whether arsenite could affect HIF-1α protein translation and whether inhibition of Raf/ ERK/S6 pathway by p27 would attenuate it, we first checked HIF-1α induction by arsenite in p27+/+ and p27 − / − (Δ51) cells. As shown in Figure 7a , compared with the mild induction of HIF-1α in p27+/+ cells, a remarked accumulation of HIF-1α protein was observed in p27 − / − (Δ51) cells. The inhibition of HIF-1α induction by p27 was further extended in p27 − / − (FL) and p27+/+ cells (Figure 7b ). In addition, the transcription of vegf, a well-defined downstream target of HIF-1α, was also found upregulated in p27 − / − (Δ51) cells in response to arsenite treatment (Figure 7c ). While the real-time PCR result clearly indicated that the mRNA level of hif-1α was not upregulated in p27 − / − (Δ51) cells (Figure 7d ), suggesting that p27 might regulate HIF-1α induction by arsenite through a translational or posttranslational mechanism. Considering our previous work showing that arsenite was involved in prevention of HIF-1α protein degradation, we checked the protein turnover rate of HIF-1α using cycloheximide (CHX), a protein synthesis inhibitor, to block the de novo production of proteins. As shown in Figure 7e , HIF-1α protein was firstly accumulated by treatment of 20 μM arsenite plus 10 μM MG132 for 6 h in both p27+/+ and p27 − / − (Δ51) cells. After removal of arsenite and MG132, HIF-1α protein began to degrade in the presence of CHX at a comparable rate in these two cell lines (Figure 7e ), suggesting that p27 did not alter the protein turnover process of HIF-1α. Subsequently, we used rapamycin to interfere with mTORC1 activity and found that it reduced HIF-1α induction in p27 − / − (Δ51) cells (Figure 7f ), indicating that p27 inhibited HIF-1α translation. To this end, short-term pulse-labeling assay was used to examine HIF-1α protein translational process in both p27+/+ and p27 − / − (Δ51) cells. As shown in Figure 7g , the incorporation of 35 S-methionine/cysteine into newly synthesized HIF-1α protein was gradually increased along with the isotope incubation time in both p27+/+ and p27 − / − (Δ51) cells. By normalizing over the global protein synthesis rate, the HIF-1α protein synthesis rate was much higher in p27 − / − (Δ51) cells than that in p27+/+ cells, indicating that p27 interfered with HIF-1α protein translation upon arsenite exposure. We further knocked down S6 expression by two sets of shRNAs in p27 − / − (Δ51) cells (Figure 7h) , and found that HIF-1α protein induction by arsenite was reduced accordingly (Figure 7i ). Considering the fact that S6, unlike its phosphorylation, is a critical protein for functional ribosomes so that its complete absence or the lack of even just one allele leads to early embryonic lethality 34 or to blockage of T-cell proliferation, 17 knockdown of S6 may only suggest that HIF-1α synthesis is highly sensitive to the compromised ribosome activity. To show explicitly the role of S6 phosphorylation in HIF-1α protein translation under the control of the p27 signaling in arsenite response, we introduced S6 S235/236A double mutant, which specifically abolished phosphorylation of Ser235/236 in endogenous S6. 18 As shown in Figure 7j , ectopic expression of HA-S6 S235/236A in p27 − / − (Δ51) cells efficiently attenuated arseniteinduced HIF-1α upregulation. In line with this, HIF-1α protein synthesis detected by pulse-labeling assay was markedly repressed by the introduction of HA-S6 S235/236A in p27 − / − (Δ51) cells (Figure 7k ), suggesting that p27 inhibited HIF-1α translation in an S6-phosphorylation-dependent manner in arsenite response. Figure 7 P27 represses HIF-1α induction by arsenite at the translational level. P27 − / − (Δ51) (a) and p27 − / − (FL) cells (b) and their respective wild-type cells were seeded into 6-well plates and cultured overnight in the normal medium containing 10% FBS. Then, the cells were starved for 36 h in the fresh medium with 0.1% FBS. Later, the cells were exposed to arsenite for 12 h in the fresh medium with 0.1% FBS. The cells were lysed and subjected to western blotting assay for the detection of HIF-1α induction. (c) Transcription of vegf was compared between p27+/+ and p27 − / − (Δ51) cells using luciferase reporter assay following 20 μM arsenite treatment for 6 h and 12 h. (d) P27+/+ and p27 − / − (Δ51) cells were treated with 20 μM arsenite for 6 h. hif-1a mRNA expression was detected by real-time PCR. (e) P27+/+ and p27 − / − (Δ51) cells were pretreated with 10 μM MG132 and 20 μM arsenite for 6 h and exposed to 50 μg/ml CHX for 2, 4 and 6 h after the removal of MG132 and arsenite. Levels of HIF-1α were detected by western blotting assay. (f) P27+/+ and p27 − / − (Δ51) cells were treated with 20 μM arsenite in the absence or presence of 10 and 20 nM rapamycin for 12 h. HIF-1α induction was detected by western blotting. (g) Cells were exposed to 20 μM arsenite for 9 h. Newly synthesized HIF-1α protein was monitored by pulse labeling assay. (h) Two sets of short hairpin RNA (shRNA) against mouse S6 were stably transfected into p27 − / − (Δ51) cells, and the knockdown efficiency was identified using real-time PCR. (i) The stable transfectants of S6 shRNA and nonsense control cells were treated with 20 μM arsenite for 6h and 12 h. The cells were lysed and subjected to western blotting assay to detect HIF-1α induction. (j and k) HA-S6 K235/236A plasmid was transfected into p27 − / − (Δ51) cells. HIF-1α induction by arsenite was assessed by western blotting (j) and protein synthesis was detected by pulse labeling assay after arsenite treatment for 9 h (k)
arsenite induces cell transformation in vitro. 35 Stable transfectants of Cl41 nonsense control and shRNA p27 were subjected to repetitive arsenite treatment at 1.25 μM. Soft agar assays were carried out monthly to trace phenotypic change of anchorage-independent cell growth, which was used as an indicator of cell transformation. As shown in Figure 8a , when arsenite exposure was accumulated to 3 months, the remarkable appearance of colonies was observed in shRNA p27 transfectants in soft agar, whereas no detectable colonies were formed in control transfectants as expected since our previous work showed that in parental Cl41 cells it took up to 6 months to induce cell transformation by 1.25 μM arsenite exposure. 35 As p27 is known to regulate cell proliferation and apoptosis, we carried out clonogenic assays to quantify the overall rates of cell growth. As shown in Figure 8b , chronic arsenite treatment readily led to significant reduction in cell viability in both Cl41 nonsense and shRNA p27 cells at comparable rates (65.30 ± 0.9% versus 59.63 ± 1.8%), indicating that the upregulation of cell transformation observed in Cl41 shRNA p27 cells might not be caused by proliferative factors. We further found that the major pathways that were identified to be deactivated by p27 in acute arsenite exposure were reproduced in the chronic arsenite exposure. As shown in Figure 8c , upregulation of ERK/S6 phosphorylation and HIF-1α induction by arsenite were observed in shRNA p27 transfectants as compared with those in control transfectants. To further verify whether HIF-1α was the driving force of chronic arsenite-induced cell transformation in the absence of p27, we knocked down HIF-1α expression in shRNA p27 cells. As shown in Figure 8d , introduction of shRNA HIF-1α markedly reduced HIF-1α protein expression as well as hypoxia-responsive element (HRE) reporter luciferase activity, which reflected HIF-1α-dependent transcription factor activity. HRE has a core binding consensus of RCGTG (R: A/G), which is conserved in more than one hundred hypoxia-responsive genes and also has strong affinity toward HIF-1α and HIF-2α. 36 Therefore, we further checked whether there was any interaction between these two isoforms. We found that knockdown HIF-1α marginally affected HIF-2α expression, indicating that interfering HIF-1α had little effects on HIF-2α activity (Figure 8d ). Soft agar assay results showed that more colonies were found in shRNA p27 cells compared with those of control cells after chronic arsenite treatment for 6 months (Figure 8e) , which was consistent with what we observed in 3-month arsenite treatment cells (Figure 8a ). More importantly, knockdown of HIF-1α efficiently reversed cell transformation of shRNA p27 cells (Figure 8e ), suggesting that it might be through regulating HIF-1α protein expression that p27 achieved its inhibitory effect in arsenite-induced cell transformation. The overall HIF-1α expression at the cellular level was detected using immunocytochemistry (Figure 8f ). Therefore, we came to our final conclusion, as delineated in Figure 8f , that by maintaining PHLPP expression, p27 blocked the activation of oncogenic Ras/Raf/MEK/ERK pathway in response to both acute and chronic arsenite exposure, led to inhibition of S6 activation in a p90RSK-dependent manner and consequently attenuated protein translation of HIF-1α, a key transcription factor involved in chronic arsenite-induced cell transformation.
Discussion
Although a variety of research studies has shown that p27 performs cyclin-CDK-independent functions such as mediation of apoptosis, cytoskeleton rearrangements and transcriptional regulation, 23, 24, [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] the effect of p27 on modulation of protein translation remains largely untouched up to now. Protein translation is a temporally and spatially wellrecognized cellular event, and the deregulation of this process contributes greatly to tumor development. 48 In our current studies, we investigated the role of p27 in arsenite-induced protein translation and its biological significance, as well as the underlying mechanisms. Our findings clearly showed that the depletion of p27 expression by knockdown and knockout approaches resulted in an obvious elevation of S6 phosphorylation, indicating that loss of p27 leads to abnormal activation of the key molecule involved in the specific protein translation, such as HIF-1α.
By tracking the upstream pathways responsible for S6 phosphorylation, we found that neither p70S6K nor AKT was involved based on the findings that knocking down p70S6K and loss of the kinase activity of AKT by introducing dominantnegative mutations, K197M and T308/S473A, did not alter S6 phosphorylation. In contrast, blockage of Ras/Raf/MER/ERK pathway by transfecting dominant-negative Ras (S17N) and ERK1/2 (K71/52R) into p27 − / − (Δ51) cells attenuated S6 phosphorylation, suggesting that p27 negatively controlled S6 activation by inhibiting the Ras/Raf/MER/ERK/p90RSK pathway. The mechanistic investigation further revealed that p27 maintained PHLPP protein expression, which hampered Ras activation. PHLPP is a newly identified family of Ser/Thr PP and catalyzes the dephosphorylation of a conserved regulatory motif, the hydrophobic motif, on the AGC kinases of AKT, PKC and p70S6K, as well as an inhibitory site on the kinase Mst1, to inhibit cellular proliferation and induce apoptosis. 49 Therefore, PHLPP is generally regarded as a novel tumor suppressor, and the frequent deletion of PHLPP is observed in human cancers. 49 The recent findings further showed that PHLPP possessed a novel function in inhibiting Ras activation. 32, 33 Distinct from the mechanisms of GAPs, PHLPP binds to the nucleotide-free Ras, which occurs during Ras switching from GTP-bound form to GDP-bound form, and in turn abrogates Ras binding with GTP, further leading to repression of downstream ERK pathway activation. 32, 33 PHLPP expression can be regulated at the translational level by miR-190 in a p50-dependent manner; 50, 51 however, p27 might control PHLPP expression in an miR-190-independent manner (Zhang and Huang et al., unpublished data).
A malignant tumor develops across time, going through the stages of initiation, promotion and progression. 52 To observe the tumor induction by chemical carcinogens reproducibly and quantitatively, an in vitro assay called cell transformation was developed to detect the conversion of normal cells to tumor cells in culture. Cell transformation is a complex process that involves many transcription factors and the genes that they regulate. 53 Arsenite induces cell transformation of various types of cells to a more malignant phenotype at relatively low doses that represent the exposure concentrations in nature environment. 53, 54 It has been demonstrated that the hypoxia signaling pathway is affected by exposure to arsenic, and chronic exposure to low-dose arsenite induced HIF-1α protein expression, which contributed to tumor angiogenesis. 55 We took advantage of the normal mouse epidermal Cl41 cell model to further exploit the potential of p27 in the inhibition of arsenite-induced cell transformation. By tracing the gain of transformation potential using soft agar monthly, we successfully caught a time window during which control transfectants did not manifest transformation characteristic while shRNA p27 transfectants already gained the anchorage-independent growth properties after 3 months of arsenite treatment. By checking the expression profiles of arsenite chronically treated cells, we were excited to reveal that the verified signal pathway that was negatively modulated by p27 in response to acute high-dose arsenite was exactly reproduced in the transformed cells. Therefore, it is concluded that the attenuation of Ras/Raf/MEK/ERK/p90RSK pathway by p27 might result in the abrogation of S6-dependent HIF-1α protein translation and arsenite-induced cell transformation as a result.
In summary, from a novel point of view, our findings provided strong evidence for the suppressive effect of p27 in the process of HIF-1α protein synthesis in arsenite responses by regulating the PHLPP-Ras-ERK-p90RSK-S6 axis, which may help to upgrade our understanding about the tumor-suppressive functions of p27.
